Estimands and their Estimators for Clinical Trials Impacted by the COVID-19 Pandemic: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions

Kelly Van Lancker, Sergey Tarima, Jonathan Bartlett, Madeline Bauer, Bharani Bharani-Dharan, Frank Bretz, Nancy Flournoy, Hege Michiels, Camila Olarte Parra, James L Rosenberger, Suzie Cro

Department of Mathematical Sciences
Centre for Mathematics and Algorithms for Data (MAD)

John Hopkins University
Ghent University
Medical College of Wisconsin
University of Southern California
Novartis Pharmaceuticals
Novartis Pharma AG
Medical University of Vienna
University of Missouri
Pennsylvania State University
Imperial College London

Research output: Contribution to journal › Comment/debate › peer-review

16 Citations (SciVal)

82 Downloads (Pure)

1 results

Finished
Clinical trial estimands - from definition to estimation
Bartlett, J. (PI)
MRC
16/11/20 → 4/09/22
Project: Research council

Estimands and their Estimators for Clinical Trials Impacted by the COVID-19 Pandemic: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions

Projects

Search results

Clinical trial estimands - from definition to estimation